Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E29.39 EPS (ttm)6.68 Insider Own11.70% Shs Outstand908.80M Perf Week0.40%
Market Cap186.95B Forward P/E22.62 EPS next Y8.68 Insider Trans-0.74% Shs Float857.17M Perf Month5.53%
Income6.09B PEG2.38 EPS next Q1.90 Inst Own83.00% Short Float1.04% Perf Quarter-5.35%
Sales25.49B P/S7.34 EPS this Y36.90% Inst Trans-0.70% Short Ratio2.61 Perf Half Y35.54%
Book/sh7.59 P/B25.85 EPS next Y9.85% ROA13.60% Target Price212.36 Perf Year23.89%
Cash/sh3.20 P/C61.27 EPS next 5Y12.37% ROE113.60% 52W Range129.21 - 218.00 Perf YTD16.21%
Dividend3.40 P/FCF52.02 EPS past 5Y24.60% ROI22.60% 52W High-10.00% Beta0.23
Dividend %1.73% Quick Ratio1.10 Sales past 5Y4.20% Gross Margin75.90% 52W Low51.85% ATR3.37
Employees35000 Current Ratio1.40 Sales Q/Q16.10% Oper. Margin22.10% RSI (14)63.06 Volatility1.60% 1.79%
OptionableYes Debt/Eq2.35 EPS Q/Q-7.00% Profit Margin23.90% Rel Volume0.53 Prev Close194.94
ShortableYes LT Debt/Eq2.35 EarningsApr 27 BMO Payout45.70% Avg Volume3.41M Price196.21
Recom2.10 SMA203.68% SMA503.58% SMA20015.79% Volume1,823,874 Change0.65%
Jan-19-21Upgrade Mizuho Neutral → Buy $164 → $222
Dec-10-20Upgrade Wolfe Research Peer Perform → Outperform $147 → $183
Nov-10-20Resumed Bernstein Mkt Perform $150
Sep-29-20Initiated Berenberg Hold $144
Sep-03-20Upgrade Morgan Stanley Equal-Weight → Overweight $176
Jun-16-20Upgrade Guggenheim Neutral → Buy
Apr-21-20Downgrade UBS Buy → Neutral $157 → $158
Apr-09-20Downgrade Morgan Stanley Overweight → Equal-Weight $148
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
May-16-21 04:42PM  
May-14-21 04:07PM  
May-13-21 04:26PM  
10:00AM  
09:51AM  
May-11-21 09:39AM  
09:26AM  
06:45AM  
May-10-21 03:57PM  
May-09-21 11:50PM  
11:36PM  
11:36PM  
04:01AM  
May-06-21 09:32AM  
06:45AM  
05:47AM  
May-05-21 02:12PM  
02:08PM  
01:19PM  
10:00AM  
07:27AM  
07:27AM  
06:40AM  
May-04-21 03:39PM  
03:01PM  
10:07AM  
09:31AM  
07:31AM  
07:22AM  
07:00AM  
06:42AM  
06:20AM  
May-03-21 03:28PM  
10:00AM  
06:42AM  
Apr-30-21 11:24AM  
Apr-29-21 11:40AM  
Apr-28-21 10:19PM  
08:37AM  
Apr-27-21 04:12PM  
04:00PM  
02:34PM  
02:34PM  
11:49AM  
11:32AM  
10:34AM  
10:12AM  
09:51AM  
09:03AM  
08:27AM  
08:11AM  
07:45AM  
06:46AM  
06:41AM  
06:40AM  
06:25AM  
02:40AM  
Apr-26-21 07:29PM  
02:08AM  
Apr-23-21 10:01AM  
10:01AM  
08:19AM  
Apr-22-21 06:20AM  
Apr-21-21 06:52AM  
Apr-20-21 06:45AM  
Apr-19-21 10:24AM  
09:54AM  
Apr-17-21 08:42AM  
Apr-16-21 07:14AM  
07:03AM  
06:51AM  
06:48AM  
06:30AM  
04:24AM  
Apr-13-21 12:44PM  
06:30AM  
Apr-12-21 12:53PM  
08:31AM  
07:41AM  
07:16AM  
06:54AM  
06:45AM  
Apr-11-21 02:00PM  
Apr-10-21 07:03AM  
Apr-09-21 02:15PM  
09:55AM  
09:51AM  
08:43AM  
07:34AM  
06:30AM  
Apr-08-21 07:41AM  
07:01AM  
06:45AM  
Apr-07-21 07:29AM  
Apr-06-21 04:30PM  
02:30PM  
Apr-02-21 12:40PM  
Apr-01-21 08:00AM  
Mar-31-21 08:30AM  
07:31AM  
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company also provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. In addition, it offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Further, the company Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Additionally, it Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; and Junshi Biosciences. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TAI JACKSON PDirectorApr 30Buy182.841,366249,75961,195May 03 07:01 PM
Zakrowski Donald AChief Accounting OfficerApr 28Sale181.383,000544,1405,987Apr 29 08:31 PM
LILLY ENDOWMENT INC10% OwnerMar 09Sale209.7959,95912,579,032110,302,100Mar 10 02:59 PM
LILLY ENDOWMENT INC10% OwnerMar 08Sale209.69125,28426,271,092110,362,059Mar 09 12:26 PM
Hakim AnatSVP, GC & SecretaryMar 01Option Exercise0.007,92807,928Mar 03 05:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.005,445027,425Feb 03 06:29 PM
Shah Aarti S.SVP & CIDOFeb 01Option Exercise0.006,282023,369Feb 03 07:02 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0075,3870343,639Feb 03 06:57 PM
Smiley Joshua LSVP and CFOFeb 01Option Exercise0.0019,266060,702Feb 03 08:22 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,754035,400Feb 03 07:26 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Feb 01Option Exercise0.006,282010,592Feb 03 06:51 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.0012,146056,919Feb 03 06:43 PM
Norton JohnaSenior VP, Global QualityFeb 01Option Exercise0.003,435020,953Feb 03 06:38 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0015,0780115,289Feb 03 06:33 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale190.80215,00041,022,862110,487,343Jan 19 01:04 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale185.97210,00039,053,064110,702,343Jan 14 11:23 AM
LILLY ENDOWMENT INC10% OwnerJan 11Sale185.49220,00040,807,754110,912,343Jan 12 11:27 AM
Smiley Joshua LSVP and CFOOct 01Option Exercise0.007,947044,918Oct 05 12:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMSep 08Sale151.015,000755,05023,580Sep 10 04:25 PM
Mason Michael BSr. VP & Pres., Lilly DiabetesSep 01Option Exercise0.006,244021,279Sep 02 05:04 PM
Fry Stephen FSVP, HR & DiversityAug 17Sale150.647,2041,085,211100,211Aug 18 03:31 PM
LILLY ENDOWMENT INC10% OwnerJul 09Sale169.6912,9612,199,392111,132,343Jul 10 02:16 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJul 09Sale170.0011,0001,870,00018,646Jul 13 01:43 PM
LILLY ENDOWMENT INC10% OwnerJul 07Sale167.29210,00035,131,799111,145,304Jul 08 12:49 PM
LILLY ENDOWMENT INC10% OwnerJul 06Sale166.99205,00034,232,086111,379,612Jul 07 02:27 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,46805,424Jul 06 04:50 PM
LILLY ENDOWMENT INC10% OwnerJun 30Sale163.20166,83227,227,760111,560,304Jul 01 11:17 AM
LILLY ENDOWMENT INC10% OwnerJun 29Sale163.3911,4311,867,760111,727,136Jun 30 03:12 PM
LILLY ENDOWMENT INC10% OwnerJun 26Sale163.0131,7375,173,404111,738,567Jul 01 09:55 AM
LILLY ENDOWMENT INC10% OwnerJun 26Sale163.0131,7375,173,404111,738,567Jun 30 02:48 PM
LILLY ENDOWMENT INC10% OwnerJun 18Sale161.5453,7708,686,046111,770,304Jun 19 02:21 PM
LILLY ENDOWMENT INC10% OwnerJun 17Sale161.38161,23026,019,469111,824,074Jun 18 05:16 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJun 16Sale162.9417,0002,770,00029,646Jun 18 09:36 AM
LILLY ENDOWMENT INC10% OwnerJun 16Sale162.92212,33734,593,145111,985,304Jun 17 03:13 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJun 05Sale150.0010,0001,500,00046,646Jun 09 04:52 PM